Targeting PELI1 in Chronic Myeloid Leukemia (CML)
Recent clinical insights published this week highlight the targeting of PELI1 as a breakthrough strategy for Chronic Myeloid Leukemia (CML). By inhibiting this specific protein, researchers aim to eliminate resistant ... Read More